We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

BioScience and BioMedicine

From Taylor & Francis

Looking to place your work in a leading cell biology journal?

 

Taylor & Francis has an interdisciplinary cell biology portfolio within BioScience and BioMedicine that's accessible to a worldwide network of authors and readers. Our journals publish high impact research helping to improve health and disease treatment, from biochemistry, drug discovery, protein disorders, artificial cells, tissue engineering and nanomedicine.

We offer hybrid and fully open access publishing options, making it easy to comply with funder mandates and show support for the movement towards open research and open science. Each journal has a peer review process that will validate your research, and eventually publish the best version of your manuscript — a task that only quality editors and peer reviewers can be trusted with. Browse the relevant titles below and find out more about each journal by clicking-through to the Aims & Scope or submit a manuscript.

 

Open Access Journals

 

Open Access makes published academic research freely and permanently available online. Anyone, anywhere can access OA research, increasing its visibility and readership. If you choose to publish with us, there is a wide range of open access options available to you. This means you can comply with any funder requirements and ensure your research makes a difference.

Open Access BioMedicine

Journal of Extracellular Vesicles

2018 Impact Factor: 11.000 — The leading publication for extracellular vesicles research worldwide. Read more about the Aims & Scope and Editorial Board.

Artificial Cells, Nanomedicine and Biotechnology

2018 Impact Factor: 4.462 — Covering the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers and tissue engineering. Read more about the Aims & Scope and Editorial Board.

Journal of Enzyme Inhibition and Medicinal Chemistry

2018 Impact Factor: 4.027 — An interdisciplinary journal publishing new knowledge and findings on enzyme inhibitors, inhibitory processes and more. Read more about the Aims & Scope and Editorial Board.

Open Access BioScience

Virulence

2018 Impact Factor: 4.775 — The first international peer-reviewed journal of its kind to focus exclusively on microbial pathogenicity, the infection process, and host-pathogen interactions. Read more from our Aims & Scope and Editorial Board.

Cell Adhesion & Migration

2018 Impact Factor: 3.296 — This journal focuses on the biological or pathological implications of cell-cell and cell-microenvironment interactions. Read more from our Aims & Scope and Editorial Board.

Channels

2018 Impact Factor: 2.289 — This is an open access journal for all aspects of ion channel research. Read more from our Aims & Scope and Editorial Board.

Nucleus

2018 Impact Factor: 2.157 — This journal provides a platform to disseminate cutting-edge research on all aspects of biology of the cell nucleus. Read more from our Aims & Scope and Editorial Board.

Journal of Plant Interactions

2018 Impact Factor: 1.839 — This journal broadly publishes research that discusses interactions of plants with their surrounding environment. Read more from our Aims & Scope and Editorial Board.

Frontiers in Life Sciences

2018 Impact Factor: 1.622 — Frontiers in Life Science publishes high-quality research at the frontier of biology, with an emphasis on interdisciplinary work at the interface of the life sciences and quantitative or social sciences. Read more from our Aims & Scope and Editorial Board.

Open Select

 

Open Select ensures researchers can publish open access (OA) in over 2,600 Taylor & Francis journals, ranging across the sciences, social sciences, medicine, technology, engineering, humanities and arts. These hybrid journals publish both OA content and subscription content.

Autophagy latest issue

Autophagy

2018 Impact Factor: 11.059 — The leading journal in the field, publishing papers on all aspects of autophagic processes. Read more from our Aims & Scope and Editorial Board.

Cell Cycle latest issue

Cell Cycle

2018 Impact Factor: 3.259 — One of the largest journals in the field, publishing Nobel Prize winning authors. Read research from the 2018 Nobel Prize winners here and read more from our Aims & Scope and Editorial Board.

Fly

2018 Impact Factor: 1.550 — Fly is the first international peer-reviewed journal to focus on Drosophilia research. Read more from our Aims & Scope and Editorial Board. Don't miss our Q&A with the new editor, Howy Jacobs.

Taylor & Francis BioScience

Taylor & Francis Medicine